S&P 500   4,577.11 (-1.84%)
DOW   35,368.47 (-1.51%)
QQQ   371.11 (-2.34%)
AAPL   170.16 (-1.68%)
MSFT   303.05 (-2.30%)
FB   318.95 (-3.90%)
GOOGL   2,724.23 (-2.34%)
AMZN   3,180.07 (-1.93%)
TSLA   1,030.62 (-1.81%)
NVDA   259.37 (-3.73%)
BABA   128.46 (-2.36%)
NIO   29.73 (-3.94%)
AMD   132.04 (-3.54%)
CGC   7.76 (-7.62%)
MU   93.00 (-4.48%)
GE   102.90 (-0.25%)
T   27.29 (+0.40%)
F   24.40 (-3.14%)
DIS   152.27 (+0.22%)
AMC   18.76 (-8.80%)
PFE   54.10 (-1.55%)
ACB   5.11 (-7.26%)
BA   225.00 (-0.42%)
S&P 500   4,577.11 (-1.84%)
DOW   35,368.47 (-1.51%)
QQQ   371.11 (-2.34%)
AAPL   170.16 (-1.68%)
MSFT   303.05 (-2.30%)
FB   318.95 (-3.90%)
GOOGL   2,724.23 (-2.34%)
AMZN   3,180.07 (-1.93%)
TSLA   1,030.62 (-1.81%)
NVDA   259.37 (-3.73%)
BABA   128.46 (-2.36%)
NIO   29.73 (-3.94%)
AMD   132.04 (-3.54%)
CGC   7.76 (-7.62%)
MU   93.00 (-4.48%)
GE   102.90 (-0.25%)
T   27.29 (+0.40%)
F   24.40 (-3.14%)
DIS   152.27 (+0.22%)
AMC   18.76 (-8.80%)
PFE   54.10 (-1.55%)
ACB   5.11 (-7.26%)
BA   225.00 (-0.42%)
S&P 500   4,577.11 (-1.84%)
DOW   35,368.47 (-1.51%)
QQQ   371.11 (-2.34%)
AAPL   170.16 (-1.68%)
MSFT   303.05 (-2.30%)
FB   318.95 (-3.90%)
GOOGL   2,724.23 (-2.34%)
AMZN   3,180.07 (-1.93%)
TSLA   1,030.62 (-1.81%)
NVDA   259.37 (-3.73%)
BABA   128.46 (-2.36%)
NIO   29.73 (-3.94%)
AMD   132.04 (-3.54%)
CGC   7.76 (-7.62%)
MU   93.00 (-4.48%)
GE   102.90 (-0.25%)
T   27.29 (+0.40%)
F   24.40 (-3.14%)
DIS   152.27 (+0.22%)
AMC   18.76 (-8.80%)
PFE   54.10 (-1.55%)
ACB   5.11 (-7.26%)
BA   225.00 (-0.42%)
S&P 500   4,577.11 (-1.84%)
DOW   35,368.47 (-1.51%)
QQQ   371.11 (-2.34%)
AAPL   170.16 (-1.68%)
MSFT   303.05 (-2.30%)
FB   318.95 (-3.90%)
GOOGL   2,724.23 (-2.34%)
AMZN   3,180.07 (-1.93%)
TSLA   1,030.62 (-1.81%)
NVDA   259.37 (-3.73%)
BABA   128.46 (-2.36%)
NIO   29.73 (-3.94%)
AMD   132.04 (-3.54%)
CGC   7.76 (-7.62%)
MU   93.00 (-4.48%)
GE   102.90 (-0.25%)
T   27.29 (+0.40%)
F   24.40 (-3.14%)
DIS   152.27 (+0.22%)
AMC   18.76 (-8.80%)
PFE   54.10 (-1.55%)
ACB   5.11 (-7.26%)
BA   225.00 (-0.42%)
NASDAQ:RLYB

Rallybio News Headlines

$8.49
-0.38 (-4.28%)
(As of 01/18/2022 03:59 PM ET)
Add
Compare
Today's Range
$8.20
$8.49
50-Day Range
$8.43
$19.91
52-Week Range
$8.06
$25.78
Volume
1,038 shs
Average Volume
47,840 shs
Market Capitalization
$272.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Get Rallybio News Delivered to You Automatically

Sign up to receive the latest news and ratings for RLYB and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Rallybio Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RLYB
News Sentiment

0.87

0.32

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RLYB Articles
This Week

11

1

RLYB Articles
Average Week



Rallybio (NASDAQ:RLYB) News Headlines Today

SourceHeadline
marketbeat.com logoRallybio (NASDAQ:RLYB) Lowered to "Hold" at Zacks Investment Research
marketbeat.com - January 13 at 4:36 AM
finance.yahoo.com logoAmi Bavishi Joins Rallybio to Lead Investor Relations and Corporate Communications
finance.yahoo.com - January 18 at 8:41 AM
MarketBeat logoRallybio Corp (NASDAQ:RLYB) Insider Buys $52,750.00 in Stock
americanbankingnews.com - January 14 at 9:14 PM
insidertrades.com logoMartin Mackay Acquires 5,504 Shares of Rallybio Corp (NASDAQ:RLYB) Stock
insidertrades.com - January 12 at 9:04 PM
nasdaq.com logoWednesday 1/12 Insider Buying Report: RLYB, ZYME
nasdaq.com - January 12 at 5:40 PM
insidertrades.com logoInsider Buying: Rallybio Corp (NASDAQ:RLYB) Insider Buys 10,000 Shares of Stock
insidertrades.com - January 11 at 9:28 PM
finance.yahoo.com logoRallybio Highlights Portfolio Advances and Outlines Expected Upcoming Milestones for 2022
finance.yahoo.com - January 6 at 1:10 PM
finance.yahoo.com logoRallybio (RLYB) Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - December 1 at 12:52 PM
finance.yahoo.com logoRallybio Reports Positive Data in Its Clinical Program for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
finance.yahoo.com - December 1 at 7:51 AM
finance.yahoo.com logoRallybio Corporation to Present at the 4th Annual Evercore ISI HealthCONx Conference
finance.yahoo.com - November 24 at 1:05 PM
finance.yahoo.com logoRallybio to Present at the Jefferies London Healthcare Conference
finance.yahoo.com - November 11 at 9:45 AM
finance.yahoo.com logoRallybio Corporation Reports Third Quarter 2021 Financial Results and Recent Business Highlights
finance.yahoo.com - November 10 at 8:42 AM
nasdaq.com logoHere's Why We're Not Too Worried About Rallybio's (NASDAQ:RLYB) Cash Burn Situation
nasdaq.com - October 29 at 2:59 PM
finance.yahoo.com logoWe're Not Very Worried About Rallybio's (NASDAQ:RLYB) Cash Burn Rate
finance.yahoo.com - October 29 at 2:59 PM
finance.yahoo.com logoRallybio Corporation Reports Second Quarter 2021 Financial Results and Recent Business Highlights
finance.yahoo.com - September 9 at 8:12 AM
barrons.com logoRallybio Holdings LLC
barrons.com - August 12 at 10:36 PM
Get Rallybio News Delivered to You Automatically

Sign up to receive the latest news and ratings for RLYB and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.